Medivolve Announces Q3 2021 Results – Reaches Record Levels of Revenue
Medivolve delivered a quarter of strong results, achieving an impressive 575% increase in revenue in growth.
Medivolve Announces Closing of Private Placement
Medivolve Inc. is pleased to announce that it has closed the previously announced private placement of an aggregate of 7,142,857 units at a price per Unit of $0.07 for aggregate gross proceeds to the Company of $500,000.
Medivolve Closes Previously Announced CAN $1.2 Million Convertible Note Financing
The Company plans to use the net proceeds from the Offering to expand its operating business, enhance regulatory capital, marketing, and for general corporate purposes.
Medivolve Announces CAN $1.2 Million Convertible Note Financing and CAN $1.4 Million Equity Private Placement
Proposed Investments Would Provide the Capital to Accelerate the Runway for Growth Across Business Units and Continue Medivolve’s Mission to Deliver Value to Shareholders
Medivolve Announces New COVID-19 Testing Mobile Vans Expanding On-Site Testing Opportunities to Schools, Workplaces, and Events
Medivolve Expands Footprint with Launch of Mobile Vans Providing Free COVID-19 Testing Services in Las Vegas, Nevada, and surrounding areas.
Medivolve Announces Plans to Hire 400+ Medical Professionals
To support Medivolve’s proactive plans to provide healthcare services beyond the COVID-19 pandemic, hiring of 400+ Doctors, Physician Assistants, Nurse Practitioners, Registered Nurses, and Therapists will be hired within the next 18 months.
Medivolve Reports 236% Increase in Weekly Gross Revenue; Releases New EHR System Optimizing COVID-19 Testing Services
Medivolve’s Electronic Health Record Portal Enhances End User Experience Improving Patient Access to Records, Lab Workflow, and Reporting
Health Tech Company Medivolve Finalizes Acquisition of CalVax Licensed Marbella Pharmacy
Medivolve Closes Marbella Pharmacy Deal Supporting Next Phase of Growth in Combining Data-Driven Clinical Diagnostics, Physician Recommendations, and Prescription Medications to Help People Live Healthier Lives.
Healthcare Technology Company Medivolve Launches Initiative to Hire 30+ Software Engineers and Developers
Plans are announced to hire new talent across its design and engineering, information technology, project management, and software development teams.
Medivolve Increases Daily Revenue 76% Since Transitioning from a Cash Pay Business Model to Insurance Reimbursements
COVID-19 testing revenues increase by automating claim submissions for over 8,700 insurance carriers and respective government agencies.
Medivolve Completes Previously Announced Private Placement Financing
Medivolve closes $12M in funding needed to support strategic plan including next phase of growth for AI technology platform that will change the face of human health management.
Medivolve Announces Private Placement Financing of up to $12 Million
Medivolve announces private placement offering of units to be used for pursuing investment opportunities, marketing, and for general corporate purposes.
Marbella Pharmacy Launches Vaccine Distribution in Orange County, California
Marbella Pharmacy has received its initial allocation of the Johnson & Johnson vaccine.
Medivolve – Inspiring the Future of Human Health Management
https://www.youtube.com/watch?v=OdeIK-BSuII
Medivolve Announces Rebrand, Affirms Momentum in Health-Tech Space Under New Leadership
New Brand Supports Strategic Corporate Vision as “One Medivolve” Built for Transformation; Solidifying Mission to Address Gaps in the Nation’s Health System
New, non-invasive COVID-19 test could help detect the virus through a breath test
Developers worked to create new technology known as BlowFISH to detect the presence of the virus through directly testing respiratory droplets. WCNC – TV – NBC
Medivolve & Marvel Diagnostics Complete First Stage Clinical Testing of BlowFISH
The technology has entered the next phase toward applying for an EUA from the FDA to test for the COVID-19 virus. Medical Product Outsourcing
Medivolve Closes Acquisition of Industry-Leading Electronic Health Platform as Next Step in Transforming Human Health Management Across the United States
New platform supports Medivolve’s position as a growing health technology and services company
Medivolve Expands Portfolio of Pharmacy Acquisitions with Agreement to Acquire Outstanding Shares of CalVax Licensed Marbella Pharmacy
Acquisition will give Medivolve immediate access to pharmaceutical distribution and CalVax licensing throughout CA; near term COVID-19 vaccination allocations to follow.
Medivolve Corporate Update Webinar – May 11th 2021
https://www.youtube.com/watch?v=STjOgDQMlLo
Medivolve Announces an Investor Webinar Tuesday, May 11 at 11 am ET
Toronto, Ontario May 6, 2021 — Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) a healthcare company that seeks out disruptive technologies, ground-breaking innovations and exclusive partnerships to transform human health management, today announces that a webinar will be held on Tuesday, May 11th at 11 am ET. The webinar will feature newly appointed Medivolve CEO, David Preiner…
Medivolve Signs Agreement to Acquire Industry-Leading Electronic Health Platform as Next Step in Transforming Human Health Management Across the United States
New platform supports Medivolve’s position as a growing health technology and services company
Medivolve and Marvel Diagnostics Successfully Complete First Stage Clinical Testing of BlowFISH, a Non-Invasive Exhaled Breath Diagnostic Technology For COVID-19, Developed by a UCLA Research Team Led by Dr. Pirouz Kavehpour
Medivolve is well positioned to deliver shareholder value from its equity position in Marvel Diagnostics and the team’s successful development of BlowFISH, a non-invasive exhaled breath diagnostic technology that has cleared the first milestone in a series of clinical tests and has entered the next phase toward applying for an Emergency Use Authorization from the…
Medivolve Announces Appointment of David Preiner as New Chief Executive Officer
Toronto, Ontario April 30, 2021 — Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) a healthcare investment management company that seeks out disruptive technologies, ground-breaking innovations and exclusive partnerships to help combat COVID-19, today announced that David Preiner has been appointed Chief Executive Officer (CEO), effective immediately. Preiner will succeed Doug Sommerville, who will assist as a transitionary…
Medivolve Announces an Investor Webinar Today at 1 pm ET
Toronto, Ontario April 15th, 2021 — Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) is pleased to announce it is hosting a Corporate Update webinar, on Thursday, April 15th at 1 pm ET that will provide investors with an update on the Company’s recent business developments. Registration Link: https://us02web.zoom.us/webinar/register/WN_pRyhGijjSgCGKKsE90lMPQ Specifically, the webinar will feature Medivolve CEO Doug Sommerville as…
Collection Sites Makes Affordable FDA EUA Approved COVID-19 At-Home Testing Available Nationwide
Test Kits from Collection Sites to be sold in convenience stores and big-box retailers across the United States, expanding on its mission to bring convenient, fast and reliable COVID-19 testing to more homes, schools and businesses
Medivolve Subsidiary Collection Sites Provides March Sales Update With Total Sales of 20,574 Tests at an Average Price of $99 per Test
Medivolve announces an investor webinar Thursday April 15th at 1 pm ET.
Collection Sites, LLC Named AditxtScore™ Channel Partner to Offer AditxtScore™ for COVID-19 Immunity Status Monitoring to Mobile Testing Centres Across the United States
Toronto, Ontario April 1, 2021 — Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) today announced that its wholly owned subsidiary, Collection Sites, LLC will offer AditxtScore™ for COVID-19 through its mobile testing centres. Aditx Therapeutics (Nasdaq: ADTX), is a biotech innovation company focused on improving the health of the immune system. Collection Sites, LLC provides testing…
Medivolve Signs Agreement With California Lab, Transplant Genomics, to Offer Free COVID-19 PCR Tests Through HRSA Program
As part of the Government funded HRSA program, Collection Sites will be able to offer uninsured and undocumented patients with access to free PCR tests.
Collection Sites Launches Business to Business Sales Initiatives; Provides Update With February Sales of 30,717 Tests at an Average Price of $98 per Test
Collection Sites launched mutli-week custom testing solutions for a high-school athletics department in Redland, California and a film production company in Los Angeles as part of its new business-focused sales strategy. Further, Medivolve announces an investor webinar Tuesday, March 23th at 1 pm ET